Evaluation of the relationship between cryptogenic epilepsy and Toxoplasma gondii infection: A meta-analysis

Cryptogenic epilepsy and toxoplasmosis

Authors

DOI:

https://doi.org/10.5281/zenodo.13623146

Keywords:

Toxoplasmosis, Cryptogenic epilepsy, Meta-analysis

Abstract

This study was conducted to evaluate the relationship between toxoplasmosis and cryptogenic epilepsy (CE) by performing a meta-analysis of the results of the studies that previously discussed the relationship between Toxoplasma gondii and CE.

A systematic search was first conducted using the Web of Science, PubMed, and Google Scholar databases for meta-analysis. Jamovi (Ver. 2.4.1.0) statistical analysis program was used for meta-analysis. The amount of heterogeneity was estimated using the restricted maximum-likelihood estimator. In addition to the estimation of tau², the Q-test for heterogeneity and the I² statistic are reported. The analysis was carried out using the log odds ratio as the outcome measure. A random-effects model was fitted to the data. Meta-analysis findings were presented as forest plots, and the correlation between T. gondii infection and epilepsy was demonstrated by the OR and 95% CI. Effect sizes of correlation coefficients were interpreted according to Cohen.

It was seen that four studies included in the analysis were conducted in Egypt, three studies in Türkiye, and two studies in Iran (k:9). The results of the meta-analysis that included nine studies showed a pooled OR of 0.89 (95% CI 0.39 to 1.39). This OR value suggests a strong association between T. gondii infection and increased risk of CE according to the Cohen classification.

There was a relationship between toxoplasmosis and increased CE. However, seroprevalence studies should be performed in larger populations to better understand the relationship between CE and T. gondii. In addition, molecular studies of how T. gondii infection affects the neurological system should be performed to interpret the relationship between toxoplasmosis and CE.

FULL TEXT PDF

Downloads

Download data is not yet available.

References

Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-82. https://doi.org/10.1111/epi.12550.

Ahlatci A, Yildizhan K, Tuluce Y, Bektas M. Valproic acid attenuated PTZ-induced oxidative stress, inflammation, and apoptosis in the SH-SY5Y cells via modulating the TRPM2 channel. Neurotox Res. 2022;40(6):1979-88. https://doi.org/10.1007/s12640-022-00622-3.

Yıldızhan K, Güneş H, Taskıran AŞ. Effect of anakinra and infliximab on oxidative stress and caspase activation in Ptz-induced acute seizure in rats. Eastern Journal of Medicine. 2023;28(1):75-81.

Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia. 2010;51(4):676-85. https://doi.org/10.1111/j.1528-1167.2010.02522.x.

Aydemir S, Afshar MT, Afshar OST, Cengiz ZT, Kiraz M, Baydar C, et al. Evaluation of toxoplasma gondii in the etiology of cryptogenic epilepsy: A Case-control Study. Archives of Epilepsy. 2024;30(2):39-42. https://doi.org/10.4274/ArchEpilepsy.2023.23102.

Dubey JP, Tiao N, Gebreyes WA, Jones JL. A review of toxoplasmosis in humans and animals in Ethiopia. Epidemiol Infect. 2012;140(11):1935-8. https://doi.org/10.1017/S0950268812001392.

Flegr J. How and why Toxoplasma makes us crazy. Trends in Parasitology. 2013;29(4):156-63. https://doi.org/10.1016/j.pt.2013.01.007.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. https://doi.org/10.1186/s13643-021-01626-4.

Cohen J. Quantitative methods in psychology: A power primer. Psychol. Bull. 1992;112:1155-9.

Koloren Z, Dubey JP. A review of toxoplasmosis in humans and animals in Turkey. Parasitology. 2020;147(1):12-28. https://doi.org/10.1017/S0031182019001318.

Flegr J. Neurological and neuropsychiatric consequences of chronic Toxoplasma infection. Current Clinical Microbiology Reports. 2015;2:163-72.

Ekici A, Timuçin D, Gürbüz E, Ünlü A, Aydemir S, Yilmaz H. Investigation of the relationship between schizophrenia and toxoplasmosis in Van province, Turkey. Parasitologists United Journal. 2021;14(1):34-8.

Ayaz E, Turkoglu SA, Orallar H. Toxoplasma gondii and Epilepsy. Turkiye Parazitol Derg. 2016;40(2):90-6. https://doi.org/10.5152/tpd.2016.4708.

Virus MA, Ehrhorn EG, Lui LM, Davis PH. Neurological and neurobehavioral disorders associated with Toxoplasma gondii infection in humans. Journal of Parasitology Research. 2021;2021.

Palmer BS. Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure. 2007;16(8):657-63. https://doi.org/10.1016/j.seizure.2007.05.010.

El-Tantawy NL, El-Nahas HA, Salem D, Salem NA-B, Hasaneen BM. Seroprevalence of Toxoplasma gondii and Toxocara spp. in children with cryptogenic epilepsy. Am J Infect Dis Microbiol. 2013;1(5):92-5.

Abd El-Aal NF, Saber M, Fawzy N, Ashour WR. Sero-Prevalence of Anti-Toxoplasma gondii antibodies among patients with neuropsychiatric disorders: Epilepsy and Depression. J Egypt Soc Parasitol. 2016;46(3):729-36.

Eraky MA, Abdel-Hady S, Abdallah KF. Seropositivity of Toxoplasma gondii and Toxocara spp. in children with cryptogenic epilepsy, Benha, Egypt. Korean J Parasitol. 2016;54(3):335-8. https://doi.org/10.3347/kjp.2016.54.3.335.

Khatab AA, Soliman MA, Abd El-Naby SA, El-Dabaa SS. Probable relationship between Toxoplasma gondii and children with cryptogenic epilepsy. Menoufia Medical Journal. 2020;33(1):157.

Zibaei M, Zamani Z, Esfahani AC, Anbari K, Nazer MR. Toxoplasma infection and epilepsy: A case-control study in Iran. Neurology Asia. 2011;16(4)

Babaie J, Sayyah M, Gharagozli K, Mostafavi E, Golkar M. Seroepidemiological study of Toxoplasma gondii infection in a population of Iranian epileptic patients. EXCLI journal. 2017;16:256.

Yazar S, Arman F, Yalcin S, Demirtas F, Yaman O, Sahin I. Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seizure. 2003;12(2):107-9. https://doi.org/10.1016/s1059-1311(02)00256-x.

Akyol A, Bicerol B, Ertug S, Ertabaklar H, Kiylioglu N. Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii. Seizure. 2007;16(3):233-7. https://doi.org/10.1016/j.seizure.2006.12.008.

Published

31-08-2024

Issue

Section

Research Article

Categories

How to Cite

1.
Aydemir S, TAŞ CENGİZ Z, KUL Z, KAÇAK K, YILMAZ H. Evaluation of the relationship between cryptogenic epilepsy and Toxoplasma gondii infection: A meta-analysis: Cryptogenic epilepsy and toxoplasmosis. Neuro-Cell Mol Res. 2024;1(2):35-39. doi:10.5281/zenodo.13623146